Trial Profile
Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Therapeutic Use
- 11 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2013 Planned end date changed from 1 Dec 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 14 Sep 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.